The alginate–gelatin hydrogel scaffold proves to be a reliable and scalable model for studying GBM, offering a platform to test therapeutic approaches and improve our understanding of the role of hypoxia and HIF-1α in GBM progression and resistance. Here, HIF1A is linked to glioblastoma.